The DM patients who received insulin therapy over four times had significant lower glucose level (S4 Table and Fig 6B), which conferred a significantly reduced risk of fatal outcome (adjusted OR = 0.146; 95% CI: 0.058–0.365; P<0.001) (Table 3). The gene discussed is INS; the disease is diabetes mellitus.